NYSE ARCA | ETF
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target.
The index is designed to measure the performance of health care companies included in the S&P 500 Index.
Under normal circumstances, the fund will obtain leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 10.83% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 8.78% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 5.68% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 4.50% |
| UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 3.70% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 2.90% |
| TMO | Thermo Fisher Scientific Inc | Healthcare | Diagnostics & Research | 2.80% |
| ABT | Abbott Laboratories | Healthcare | Medical Devices | 2.77% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 2.59% |
| ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 2.54% |
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 2.39% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 1.84% |
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 1.80% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 1.76% |
| SYK | Stryker Corporation | Healthcare | Medical Devices | 1.75% |
| MDT | Medtronic PLC | Healthcare | Medical Devices | 1.71% |
| MCK | McKesson Corporation | Healthcare | Medical Distribution | 1.61% |
| BSX | Boston Scientific Corp | Healthcare | Medical Devices | 1.59% |
| CVS | CVS Health Corp | Healthcare | Healthcare Plans | 1.38% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 1.16% |